Physician

Christopher Charles Ornelas, MD

According to 2025 Medicare claims, Christopher Ornelas, MD (NPI: 1568637239) practices interventional pain management (ipm) in the Los Angeles-Long Beach-Glendale, CA market, with the plurality of this provider's patient population coming from Los Angeles, CA. This provider's primary affiliated billing organization is USC CARE MEDICAL GROUP, INC (NPI: 1902846306; TIN: 954540991) and primary practice location at 90245-2818. Ornelas is affiliated with the Caravan Collaborative Pathways (ACO ID: A4604) and Lore Health ACO (ACO ID: A5192), participating under the MSSP model.

Ornelas' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,013 traditional Medicare patients, billed 5,260 HCPCS/CPT codes, and received $390,990 in Medicare payments. The top billing code was 64483 (Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level). Part D data shows 131 prescription claims across 85 beneficiaries totaling $1,438 in drug costs, led by Gabapentin (Gabapentin). Open Payments data shows 12 records totaling $736. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $121,216 to $390,990. In contrast, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $4,537 to $1,438. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.